NMR serum metabolomics for understanding the pathophysiology of COPD associated PH: A pilot study Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018
GWA to study the genetics of asthma and in other diseases - advances and challenges Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008
How to define asthma in large-scale studies? Source: International Congress 2014 – Is asthma prevalence still increasing? Year: 2014
Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study Source: International Congress 2019 – M-health/e-health II Year: 2019
Scene-setting: why do we need genomics and proteomics to understand pathology? Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013
HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012
Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design Source: ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020 Year: 2020
Omics in population studies: a molecular epidemiology perspective in chronic airway disease Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014
Genetics, genomics and a systems approach to asthma Source: Annual Congress 2008 - “Omics” and systems biology: the promise of future disease understanding Year: 2008
COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
Detailed physiological profiling of patients for a study investigating the airway microbiome Source: International Congress 2018 – Innovations in equipment and their application Year: 2018
From research question to dissemination: how to design, analyse and present study results Source: Breathe, 14 (3) 232; 10.1183/20734735.020018 Year: 2018
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020
Utilising data from single cell approaches to study existing and recently emerging lung diseases? Source: Virtual Congress 2021 – Utilising data from single cell approaches to study existing and recently emerging lung diseases? Year: 2021
Some current challenges in statistical methods to illuminate disease genetics Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008
COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007
Genome-wide association study identifies new COPD risk locus, PDE4D, in Korean population Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013